Filing Details

Accession Number:
0001415889-22-009176
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-30 16:34:48
Reporting Period:
2022-08-29
Accepted Time:
2022-08-30 16:34:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
815094 Abiomed Inc NASD Surgical & Medical Instruments & Apparatus (3841) 042743260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1821352 A Marc Began C/O Abiomed, Inc.,
22 Cherry Hill Drive
Danvers MA 01923
Vp & General Counsel No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Disposition 2022-08-29 500 $255.95 15,785 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $266.39 2020-05-30 2029-05-30 0 7,000 Direct
Common Stock Stock Option (Right to Buy) $223.90 2021-05-29 2030-05-29 0 5,125 Direct
Common Stock Stock Option (Right to Buy) $283.88 2022-05-25 2031-05-25 0 2,961 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2029-05-30 0 7,000 Direct
2030-05-29 0 5,125 Direct
2031-05-25 0 2,961 Direct
Footnotes
  1. Sale of common stock pursuant to reporting owner's 10b5-1 plan.
  2. This price represents the sale price of the transactions on the reported date at $259.9500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  3. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
  4. These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.